INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,329 Cr | ₹748 Cr | ₹612 Cr | ₹404 Cr | ₹254 Cr |
What is the latest Total Liabilities ratio of INNOVA CAPTAB ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,329 Cr |
Mar2023 | ₹748 Cr |
Mar2022 | ₹612 Cr |
Mar2021 | ₹404 Cr |
Mar2020 | ₹254 Cr |
How is Total Liabilities of INNOVA CAPTAB Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,329 Cr | 77.68 | |
Mar2023 | ₹748 Cr | 22.22 | |
Mar2022 | ₹612 Cr | 51.35 | |
Mar2021 | ₹404 Cr | 59.16 | |
Mar2020 | ₹254 Cr | - |
Compare Total Liabilities of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹5,043.3 Cr | 1.7% | -0% | 89.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -2% | -8.4% | 14.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,673.0 Cr | -0.2% | 7.5% | 48% | Stock Analytics | |
CIPLA | ₹118,908.0 Cr | -0.3% | -2.6% | 0.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,106.0 Cr | -1% | -4.1% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,494.0 Cr | 0.3% | 8% | 6.2% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | 1.7% |
-0% |
89.1% |
SENSEX | -0.4% |
0.3% |
8.7% |
You may also like the below Video Courses